Effective weight loss with Saxenda

Getting rid of excess weight and correcting figure flaws are often given with great difficulty. Some areas are especially difficult to put in order – a double chin folds at the waist, hips, and abdomen. Modern cosmetology has drugs that can be used to correct just such local deposits of adipose tissue and achieve impressive results. Lipolitics do an excellent job with this task. And the product of the Korean manufacturer has adequately established itself in the market of cosmetic and medical preparations.

Saxenda weight loss pen is an FDA-approved prescription injectable that, when used with a low-calorie diet and increased physical activity, may help some overweight adults who also have weight-related medical problems (such as high blood pressure, and high blood pressure). ). cholesterol or type 2 diabetes) or obesity in order to lose weight and keep it off.

Saxenda is not intended for the treatment of type 2 diabetes and should not be used with Victoza® or any other GLP-1 receptor agonist or insulin. It is not known whether Saxenda is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products.

What is Saxenda pen injector?

Saxenda Injection (active substance – lliraglutide) 3 mg is an injectable prescription drug that may help some overweight adults (BMI >/= 27) who also have weight-related medical issues or obesity (BMI >/= 30), lose weight, and keep weight loss. Saxenda should be used with a reduced calorie diet and increased physical activity.

How to use the product?

Give your dose of Saxenda under the skin (subcutaneous injection) in the abdomen (abdomen), thigh (thigh), or upper arm as directed by your health care provider. Do not inject into a vein or muscle

Never share your Saxenda pen or needles with other people.

Therapy with saxenda injection pen should be discontinued if, after 12 weeks of using the drug at a dose of 3 mg/day, the loss in body weight was less than 5% of the initial value. The need for continued therapy should be reassessed annually.

Missed dose. If less than 12 hours have elapsed since the usual dosing time, the patient should administer a new dose as soon as possible. If less than 12 hours are left before the usual time for the next dose, the patient should not take the missed dose, but should resume the drug at the next scheduled dose. Do not administer an additional or increased dose to compensate for the missed one.

Patients with type 2 diabetes. Saxenda should not be used in combination with other GLP-1 receptor agonists.

At the beginning of therapy with Saxenda, it is recommended to reduce the dose of concomitantly used insulin secretagogues (such as sulfonylurea drugs) to reduce the risk of hypoglycemia.

Special groups of patients

Elderly patients (≥65 years). Dose adjustment based on age is not required. The experience of using the drug in patients aged ≥75 years is limited, the drug should be used with caution in such patients.

Kidney failure. In patients with mild or moderate renal impairment (Cl creatinine ≥30 ml/min), dose adjustment is not required. There is limited experience with Saxenda in patients with severe renal impairment (Cl creatinine <30 ml/min). The use of Saxenda in such patients, including patients with end-stage renal disease, is contraindicated.

Impaired liver function. In patients with mild or moderate hepatic impairment, dose adjustment is not required. In patients with mild or moderate hepatic impairment, the drug should be used with caution. The use of Saxenda in patients with severe hepatic impairment is contraindicated.

Women should stop therapy with Saxenda® when planning or becoming pregnant.

Children. The use of Saxenda in children and adolescents under 18 years of age is contraindicated due to the lack of data on safety and efficacy.


  1. Read this leaflet carefully before using the Saxenda pre-filled pen.
  2. Use a pen only after the patient has learned to use it under the guidance of a doctor or nurse.
  3. Check the label on the pen label to make sure it contains Saxenda 6 mg/mL, and then carefully study the illustrations below, which show parts of the pen and needle.
  4. If the patient is visually impaired or has severe visual problems and cannot read the numbers on the dose counter, do not use the pen without assistance. A person without visual impairment who has been trained in the correct use of the Saxenda pre-filled pen can help.